Teva Soars, Sanofi Gains on Strong Trial Results for IBD Treatment

Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, according to the companies.

Topics

Bayer Eye Drug Shows Positive Results in Late-Stage Trial

Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
The Wall Street Journal - 11h
AI chipmaker Broadcom shares soar 17% despite mixed quarterly results — here's why

We're increasing our price target on the stock after a slew of positive AI updates.
CNBC - 4d
Domestic violence survivors receive treatment for brain injuries

The Rockefeller Neuroscience Institute at West Virginia University is working to treat domestic violence survivors for any brain injuries. NBC News’ Kate Snow spoke with a survivor who is receiving ...
NBC News - Dec. 10
CervoMed’s stock craters 77% after failed trial of treatment for rare brain disease

CervoMed Inc.’s stock cratered early Tuesday after the biotech company said a midstage trial of a treatment for patients with dementia with Lewy bodies, or DLB, failed to meet its main goals.
MarketWatch - Dec. 10
Rivian’s stock soars 13% after it’s named a strong contender in EV market over next 10 years

Benchmark starts coverage with a buy rating and price target offering a 38% upside.
MarketWatch - Dec. 9
The Tennessee Trans Treatment Case Is About Age, Not Sex

The state’s ban on gender-affirming medical care for minors passes the constitutional test.
The New York Times - Dec. 8
Seeding Change: A Guide to Bountiful Results

The proptech revolution improves tenants’ lives, while making management easier and more efficient.
Inc. - Dec. 7
Terns’s stock soars as analysts cheer leukemia data — and predict more gains

The pharma company now has two positive proof-of-concept trials under its belt, including its weight-loss pill.
MarketWatch - Dec. 4
Sanofi to Invest $1 Billion in New Insulin Manufacturing Base in China

The new base, which will be located in Yizhuang, Beijing, marks Sanofi’s second production site in the capital and its fourth in the country.
The Wall Street Journal - Dec. 3